can i make a crypto coin, snippets

Kunlun Unicom and Anheng Information signed a cooperation agreement. On December 11th, Beijing Kunlun Unicom Technology Development Co., Ltd. and Anheng Information signed a cooperation agreement for Beijing regional general generation in Beijing. In this cooperation, Kunlun Unicom will rely on Anheng Information's professional technology and products in the field of digital security to further enrich its solution system and provide customers with more comprehensive information technology services. At the same time, Anheng Information will also rely on Kunlun Unicom's extensive customer resources and market channels to expand its market business in Beijing.JPMorgan Chase: The target price of Netflix was raised from $850 to $1,010, and the "overweight" rating was maintained.Spain's CPI monthly rate in November was 0.2%, expected to be 0.2%, and the previous value was 0.20%. Spain's CPI annual rate in November ended at 2.4%, with an expected 2.4% and a previous value of 2.40%. Spain reconciled CPI monthly rate in November with the final value of 0%, the expected value of 0% and the previous value of 0.00%. Spain's November harmonized CPI annual rate ended at 2.4%, with an expected 2.4% and a previous value of 2.40%.

Jiangxi procuratorate prosecuted Gao Zhunhu's suspected bribery case according to law. Recently, Gao Zhunhu (deputy department level), former deputy secretary and vice chairman of Jingdezhen CPPCC in Jiangxi Province, was under the jurisdiction of Jiangxi Provincial People's Procuratorate, and Pingxiang Municipal People's Procuratorate filed a public prosecution with Pingxiang Intermediate People's Court according to law. The case is being further processed. At the stage of examination and prosecution, the procuratorate informed the defendant Gao Zhuhu of his litigation rights according to law, interrogated the defendant according to law and listened to the opinions of the defenders. The Pingxiang Municipal People's Procuratorate sued the accusation: the defendant Gao Zhuhu used to be the secretary, deputy secretary and director of the Party Working Committee of Jingdezhen Ceramic Industrial Park, the secretary of the Party Working Committee of Jingdezhen Central City Changnan Development Zone, the party secretary and chairman of Jingdezhen Urban Construction and Development Investment Co., Ltd., the party secretary and chairman of Jingdezhen Urban Construction Investment Group Co., Ltd., and the party working Committee secretary of Jingdezhen Changnan New District. Jingdezhen High-tech Industrial Development Zone, deputy secretary of the Party Working Committee, director of the management committee and other positions, seek benefits for others, illegally accept other people's property, the amount is particularly huge, and should be investigated for criminal responsibility for accepting bribes according to law.Shanghai Electric established a new company including machinery and equipment sales business. According to the enterprise search APP, Shanghai Dixi New Energy Co., Ltd. was established with Ye Can as its legal representative and registered capital of 1 million yuan. Its business scope includes: power generation business, power transmission business and power supply (distribution) business; Installation, maintenance and testing of power transmission, power supply and power reception facilities; Mechanical equipment sales; Mechanical and electrical equipment sales, etc. Enterprise survey shows that the company is wholly owned by Shanghai Electric New Energy Development Co., Ltd., a subsidiary of Shanghai Electric.Ha Sanlian: Four kinds of drugs are planned to win the bid for national centralized procurement. Ha Sanlian announced that the company and its wholly-owned subsidiary Lanxi Pharmaceutical participated in the tenth batch of national centralized procurement of drugs organized by the state. The company's esmolol hydrochloride injection, pentoxifylline injection, potassium chloride injection, and tandospirone citrate tablets of Lanxi Pharmaceutical intend to win the bid for this centralized procurement. If the subsequent purchase contract is signed and implemented, it will help to expand the sales of related products and improve the market share and brand influence. The prices of the above-mentioned drugs are respectively 1.34 yuan for esmolol hydrochloride injection, 0.59 yuan for pentoxifylline injection, 0.16 yuan for potassium chloride injection and 6.56 yuan for tandospirone citrate tablets.

Dutch International: Britain's economic growth momentum has further slowed down, but the budget boost is coming. Dutch International Bank said that Britain's GDP fell again in October, although this may exaggerate the degree of recent economic slowdown. According to the bank's forecast of Britain's annual GDP in 2025, the British economy will surpass most western European countries next year. This may tell more about the economic health of other parts of continental Europe, but it also reflects the impact of the recent fiscal stimulus measures in Britain to a great extent. Compared with the budget of the last Conservative government, public expenditure has increased by about 60 billion pounds, accounting for more than 2% of GDP. Most of the increased expenditure will flow to government departments in the form of daily funds, and most of it will eventually appear in the form of wages. Therefore, the transmission of finance to broader economic growth may be quite high.Shenzhen Longgang Yueke Artificial Intelligence Venture Capital Fund was established with a capital contribution of 1 billion yuan. According to Tianyanchao App, recently, Shenzhen Longgang Yueke Artificial Intelligence Venture Capital Fund Partnership (Limited Partnership) was established. The executive partner is Guangdong Yueke Parent Fund Investment Management Co., Ltd., with a capital contribution of 1 billion yuan. The business scope is to engage in equity investment, investment management, asset management and other activities with private equity funds. Shenzhen Longgang District Guide Fund Investment Co., Ltd. and Guangdong Emerging Industry Investment Fund Partnership.Hengrui Pharma: SHR-2173 injection was approved for clinical trial. Hengrui Pharma announced that its subsidiary, Guangdong Hengrui Pharma Co., Ltd., received the Notice of Approval for Clinical Trial of SHR-2173 injection approved and issued by National Medical Products Administration, and agreed to carry out clinical trial. The indication is lupus nephritis. SHR-2173 injection is a therapeutic biological product independently developed by the company, and the research and development expenses have been invested about 45.03 million yuan. The period from research and development to listing of drugs is long, there are many links, and there are uncertain factors. The company will actively promote research and development projects and fulfill its information disclosure obligations.